Madrid

• OCEAN(a)-PreEvent - Olpasiran trials of Cardiovascular Events And LipoproteiN(a) reduction to Prevent first major cardiovascular Events Pending
  2025-520554-11-00 5 Cardiovascular Disease
• DAREON®-Lung-1: A study in people with advanced small cell lung cancer to compare obrixtamig plus atezolizumab, carboplatin, and etoposide t … Pending
  2025-520565-51-00 5 small cell lung cancer
• A Study to Assess the Safety of RG6496 in Huntington’s Disease Gene Expansion Carriers with the Selected Genetic Variant (POINT-HD) Pending
  2025-520631-17-00 1 Huntington’s Disease Gene Expansion Carriers
• Role of inhaled nitric oxide on right ventricular function and pulmonary vascular mechanics following cardiac surgery Pending
  2025-520808-10-00 5 Patients in the immediate cardiac surgery post-operative period
• CLINICAL TRIAL WITH APROTININ IN THE ACUTE RESPIRATORY DISTRESS SYNDROME TREATMENT Pending
  2025-520826-39-00 5 ACUTE RESPIRATORY DISTRESS SYNDROME
• Short-Term Anticoagulation versus Antiplatelet Therapy for Preventing Device Thrombosis Following Left Atrial Appendage Closure. The ANDES s … Pending
  2025-520954-12-00 6 Atrial Fibrillation Device thrombosis post-Left Atrial Appendage Closu
• Effects of sodium-glucose cotransporter 2 inhibition on the mechanisms of heart failure with preserved ejection fraction Pending
  2025-520969-51-00 6 Heart failure with preserved ejection fraction
• A clinical trial to learn about the effects of DAK539 on the blood levels of repaglinide, midazolam, drospirenone, and ethinyl estradiol in … Pending
  2025-521000-22-00 3 Patients with advanced malignancies
• A clinical trial to learn how liver function affects the blood levels of DAK539 in people with advanced cancer Pending
  2025-521001-40-00 3 Advanced Malignancies and Hepatic Impairment
• A maintenance study to investigate the efficacy and safety of duvakitug in participants with moderately to severely active Crohn’s disease Pending
  2025-521037-86-00 5 Immune system diseases
• A maintenance study to investigate the efficacy and safety of duvakitug in participants with moderately to severely active ulcerative coliti … Pending
  2025-521038-27-00 5 Immune system diseases
• A Study to Evaluate the Safety and Tolerability of ARV-806 in Adults with Advanced Cancer that has the KRAS G12D Mutation Pending
  2025-521062-10-00 1 KRAS G12D Mutated Advanced Solid Tumors
• Randomized clinical trial to assess the efficacy and safety of a strategy for primary prevention of cardiovascular disease in patients with … Pending
  2025-521086-28-00 6 CHRONIC INFLAMMATORY RHEUMATIC DISEASE: rheumatoid arthritis or psoria
• A Study to Determine if BHV-8000 is Effective, Safe and Tolerable as a Treatment for Adults Living With Early Parkinson's Disease Pending
  2025-521113-13-00 10 Early Parkinson’s Disease
• Safety and efficacy of treatment combination with ponatinib and asciminib in chronic myeloid leukemia patients resistant to ponatinib and/or … Pending
  2025-521126-15-00 4 Chronic Myeloid Leukemia
• RESET-Myositis: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Idiopathic Inflammatory Myopathy … Pending
  2025-521145-24-01 9 Active Idiopathic Inflammatory Myopathy including dermatomyositis, ant
• A biomarker enrichment trial of anti-EGFR agents in patients with advanced colorectal cancer (aCRC) with wild-type RAS and right primary tum … Pending
  2025-521209-42-00 6 advanced colorectal cancer with wild-type RAS and right primary tumour
• Randomized, Open-Label, Phase 3 Clinical Trial of N-803 Plus Tislelizumab and Docetaxel Versus Docetaxel Monotherapy in Participants With Ad … Pending
  2025-521221-32-00 5 Advanced or Metastatic Non-Small Cell Lung Cancer
• An Open-label Study of the Safety, Pharmacokinetics, Pharmacodynamics, and Efficacy of 12-month Treatment with Migalastat in Pediatric Subje … Pending
  2025-521244-38-00 5 Fabry disease
• Prospective, randomized, multicentre study to compare the efficacy at 52 weeks (1 year) of biosimilar teriparatide and alendronate in the pr … Pending
  2025-521301-40-00 6 Prevention of new morphometric vertebral fractures and/or worsening of
• Staphylococcus aureus Network Adaptive Platform trial (SNAP) Pending
  2025-521388-11-00 4 Staphylococcus aureus bacteraemia
• A Phase 4 Mechanistic Longitudinal Study to Evaluate the Impact of EARLY Risankizumab Treatment on TRM Cell Levels in Moderate-to-Severe Pso … Pending
  2025-521424-30-00 6 Psoriasis
• Pilot randomized controlled trial of the prevention of early respiratory tract infections in intubated patients. Comparison of the safety an … Pending
  2025-521454-42-00 6 Reduced level of consciousness associated with severe trauma, traumati
• Optimising TREATment for severe Gram-Negative Bacterial infections. Pending
  2025-521476-65-00 6 Severe Gram-Negative Bacterial infections

Showing 121–144 of 3,550 trials